$93.00
2.27[2.50%]
At close: Apr 26
$93.00
0[0.00%]
After Hours: 4:20PM EDT
Blueprint Medicines: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Apr 01, 2024 | Michael Landsittel | CHIEF FINANCIAL OFFICER | 0 | $65.53 | -$294.75K | SELL-OPTIONS | 0.00% | 47.286K | Mar 28 | View |
Mar 26, 2024 | Jeffrey Albers | -11.033K | $90.69 | -$1.00M | SELL | -6.27% | 165.017K | Mar 07 | View | |
Mar 22, 2024 | Jeffrey Albers | 0 | $47.19 | -$2.01M | SELL-OPTIONS | 0.00% | 176.05K | Mar 20 | View | |
Mar 19, 2024 | Michael Landsittel | CHIEF FINANCIAL OFFICER | -8.734K | $61.92 | -$1.03M | SELL | -15.59% | 47.286K | Mar 15 | View |
Mar 19, 2024 | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | -2.949K | $51.38 | -$375.20K | SELL | -16.51% | 14.913K | Mar 15 | View |
Mar 15, 2024 | Philina Lee | CHIEF COMMERCIAL OFFICER | -6.276K | $51.78 | -$702.30K | SELL | -15.31% | 34.729K | Mar 13 | View |
Mar 11, 2024 | Becker Hewes | CHIEF MEDICAL OFFICER | -3.097K | $90.69 | -$280.87K | SELL | -6.27% | 46.281K | Mar 07 | View |
Mar 11, 2024 | Debra DursoBumpus | CHIEF PEOPLE OFFICER | -5.093K | $90.69 | -$461.88K | SELL | -8.13% | 57.585K | Mar 07 | View |
Mar 11, 2024 | Kate Haviland | CHIEF EXECUTIVE OFFICER | -12.464K | $90.69 | -$1.13M | SELL | -7.52% | 153.177K | Mar 07 | View |
Mar 11, 2024 | Philina Lee | CHIEF COMMERCIAL OFFICER | -2.934K | $90.69 | -$266.08K | SELL | -6.68% | 41.005K | Mar 07 | View |
Mar 11, 2024 | Christopher Murray | CHIEF TECHNICAL OPERATIONS | -2.521K | $90.69 | -$228.63K | SELL | -6.93% | 33.853K | Mar 07 | View |
Mar 11, 2024 | Michael Landsittel | CHIEF FINANCIAL OFFICER | -5.003K | $90.69 | -$453.72K | SELL | -8.20% | 56.02K | Mar 07 | View |
Mar 11, 2024 | Christina Rossi | CHIEF OPERATING OFFICER | -6.07K | $90.69 | -$550.49K | SELL | -8.63% | 64.306K | Mar 07 | View |
Mar 11, 2024 | Fouad Namouni | PRESIDENT, R & D | -4.377K | $90.69 | -$396.95K | SELL | -5.68% | 72.703K | Mar 07 | View |
Mar 11, 2024 | Percy Carter | CHIEF SCIENTIFIC OFFICER | -2.286K | $90.69 | -$207.32K | SELL | -4.52% | 48.331K | Mar 07 | View |
Mar 11, 2024 | Tracey McCain | EVP AND CHIEF LEGAL OFFICER | -5.194K | $90.69 | -$471.04K | SELL | -7.91% | 60.498K | Mar 07 | View |
Mar 11, 2024 | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | -1.462K | $90.69 | -$132.59K | SELL | -7.57% | 17.862K | Mar 07 | View |
Mar 06, 2024 | Christopher Murray | CHIEF TECHNICAL OPERATIONS | 11.879K | $93.65 | -$58.16K | GRANT | 48.50% | 36.374K | Mar 01 - Mar 04 | View |
Mar 01, 2024 | Christopher Murray | CHIEF TECHNICAL OPERATIONS | 0 | $77.06 | -$229.35K | SELL-OPTIONS | 0.00% | 24.495K | Feb 28 | View |
Browse insider trades on all stocks.